Current Pharmaceutical Design
Title:Editorial: New Avenues and Therapeutic Strategies for the Treatment of Neurodegenerative Diseases
Volume: 23 Issue: 5
Author(s): Ana Raquel Esteves
Affiliation:
Export Options
About this article
Cite this article as:
Esteves Raquel Ana, Editorial: New Avenues and Therapeutic Strategies for the Treatment of Neurodegenerative Diseases, Current Pharmaceutical Design 2017; 23 (5) . https://dx.doi.org/10.2174/1381612823999170201153809
DOI https://dx.doi.org/10.2174/1381612823999170201153809 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
27
1
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Synthetic Cannabinoid Receptor Agonists and Antagonists: Implication in CNS Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Structure Activity Relationships for Nicotinamide in the Treatment of Stroke
Letters in Drug Design & Discovery Preclinical Safety and Pharmacokinetic Profile of 3K3A-APC, a Novel, Modified Activated Protein C for Ischemic Stroke
Current Pharmaceutical Design The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration
Current Neuropharmacology The gp130 Receptor Cytokine Family: Regulators of Adipocyte Development and Function
Current Pharmaceutical Design Brain Structural Effects of Psychopharmacological Treatment in Bipolar Disorder
Current Neuropharmacology α-Synuclein and the Pathogenesis of Parkinsons Disease
Protein & Peptide Letters Editorial [Continue the Great Journey of Success!]
Current Molecular Medicine The FDG-PET Revolution of Medical Imaging – Four Decades and Beyond
Current Molecular Imaging (Discontinued) Oxidative Stress in Alzheimer Patients in Different Stages of the Disease
Current Medicinal Chemistry Role and Treatment of Mitochondrial DNA-Related Mitochondrial Dysfunction in Sporadic Neurodegenerative Diseases
Current Pharmaceutical Design Editorial [Hot Topic :Current Advances In Therapeutic Applications of Nuclear Receptors (Guest Editor: Stefano Fiorucci)]
Current Topics in Medicinal Chemistry Prolyl-Specific Peptidases and Their Inhibitors in Biological Processes
Current Chemical Biology α-Synuclein Misfolding and Neurodegenerative Diseases
Current Protein & Peptide Science Designing of Novel Carbonic Anhydrase Inhibitors and Activators
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Prediction of Gene Co-Expression by Quantifying Heterogeneous Features
Current Bioinformatics The Multiple Layers of Signaling Selectivity at Protease-Activated Receptors
Current Pharmaceutical Design Quinazolines as Apoptosis Inducers and Inhibitors: A Review of Patent Literature
Recent Patents on Anti-Cancer Drug Discovery Saturation of the Human Phenome
Current Genomics The proNGF-p75NTR-Sortilin Signalling Complex as New Target for the Therapeutic Treatment of Parkinsons Disease
CNS & Neurological Disorders - Drug Targets